Human Leukocyte Antigen (HLA) Testing Market: Introduction
- Human leukocyte antigen (HLA) testing is a method of determining how closely tissue from a donor matches tissue from a recipient prior to transplantation. Due to an increase in transplant failures, there is a growing need to match the organ transplant feasibility prior to surgery in order to avoid any kind of loss. Hence, the public and private sectors have increased investment in the HLA testing market.
Global Human Leukocyte Antigen (HLA) Testing Market: Key Drivers, Restrains, and Opportunities
- Increase in public-private funding for target research activities, rise in burden of infectious diseases, surge in number of transplant procedures, and technological advancements in the field of transplant diagnostics are projected to drive demand for transplant diagnostic products.
- In terms of end-user, the global human leukocyte antigen testing market can be segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. The independent reference laboratories segment held major share of the global market in 2020. Rapid modernization and automation of diagnostic laboratories, increase in number of research & development activities outsourced by pharmaceutical and biotechnology companies to independent reference laboratories, and rise in number of organ transplantation procedures contribute to the segment's large market share.
- According to the U.S. Department of Health Services, majority of patients in need of a transplant were aged over 50 or over 64. It is caused by the organs' natural tendency to stop functioning normally after a sedentary lifestyle, as well as other cardiovascular diseases such as diabetes. Moreover, the U.S. Centers for Disease Control and Prevention (CDC) projects a surge in the geriatric population in the next few years. According to the CDC, young adults and those above 65+ will break even by 2034 and there would be a ready demand for better and advanced technology to assist them during transplants and other ailments.
- Moreover, awareness about organ donation and transplantation across the developing countries and emerging technologies boost the growth of the global HLA testing market.
- High cost of molecular tests used in HLA testing procedures is a major restraint of the global HLA testing. Additionally, large gap between the number of organ donors and the number of organs required each year is expected to hamper market growth.
North America to Capture Major Share of Global Human Leukocyte Antigen (HLA) Testing Market
- North America is a well-established medical device market. Presence of a well-developed healthcare system, high adoption of innovative transplant diagnostic technologies (including HLA typing) among medical professionals, large number of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics drive the market in North America.
- The market in Asia Pacific is likely to grow at a rapid pace in the next few years. The region's economies are strengthening, which has led to increase in investment in the healthcare sector. Increase in the global population is projected to drive demand for efficient healthcare facilities. Moreover, large patient pool is another factor propelling the human leukocyte antigen (HLA) testing market in Asia Pacific.
Major players operating in the global human leukocyte antigen (HLA) testing market are listed below:
- Thermo Fisher Scientific, Inc.
- QIAGEN N.V.
- Illumina
- CareDx, Inc.
- Immucor, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffman-La Roche Ltd.
- Hologic, Inc.
- Luminex
- Biofortuna
- Takara Bio
- Omixon
- Becton, Dickinson, and Company
- Fujirebio, Inc.
- TBG Diagnostics Ltd.
Global Human Leukocyte Antigen (HLA) Testing Market: Research Scope
Global Human Leukocyte Antigen (HLA) Testing Market, by technology
- Molecular Assay Technologies
- PCR-Based Molecular Assays
- Real-time PCR
- Sequence-specific Primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based Molecular Assays
- Sequencing-based Molecular Assays
- Sanger Sequencing
- Next-generation Sequencing
- Other Sequencing-based Molecular Assays
- Non-molecular Assay Technologies
Global Human Leukocyte Antigen (HLA) Testing Market, by Product and Services
- Reagents & Consumables
- Instruments
- Software & Services
Global Human Leukocyte Antigen (HLA) Testing Market, by Application
- Diagnostic Application
- Antibody Screening
- Chimerism Monitoring
- Others
- Research Application
Global Human Leukocyte Antigen (HLA) Testing Market, by End-user
- Independent Reference Laboratories
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
Global Human Leukocyte Antigen (HLA) Testing Market, by Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
